Ross, Adam H.
Downey, Louise
Devonport, Helen
Gale, Richard P.
Kotagiri, Ajay
Mahmood, Sajjad
Mehta, Hemal
Narendran, Niro
Patel, Praveen J.
Parmar, Nina
Jain, Nitin
Funding for this research was provided by:
Bayer UK Plc
Article History
Received: 17 September 2019
Accepted: 31 October 2019
First Online: 3 January 2020
Compliance with ethical standards
:
: All authors except NJ and NP received honoraria from Bayer plc UK. AR: Consulting fees from Bayer and Allergan; lecture fees from Bayer and Allergan. LD: Consulting and lecture fees from Bayer, Novartis, Alimera Sciences, Bausch + Lomb; grant support (travel) from Bayer, Novartis and Allergan; research funding from Bayer, Novartis, Allergan, Alimera Sciences and Roche. HD: Consulting fees from Bayer; lecture fees from Bayer; grant support (travel) from Bayer. RG: Consulting fees from Bayer and Novartis; research funding and educational grants from Bayer and Novartis. SM: Consulting fees from Bayer and Novartis; lecture fees from Bayer and Novartis; grant support (travel) from Bayer and Novartis; research funding from Roche. HM: Consulting fees from Bayer, Novartis, Roche and Allergan; research funding from Bayer, Novartis, Roche and Allergan. NN: Consulting fees from Bayer and Novartis; lecture fees from Bayer and Novartis; grant support (travel) from Bayer and Novartis. PJP: Consulting fees from Bayer and Novartis; research funding and educational grants from Bayer. NP: Owns Bayer shares and is employed by Bayer plc UK serving as a Medical Science Liaison. NJ: Owns Bayer shares and is employed by Bayer plc UK serving as a Senior Medical Advisor and MSL manager (Specialty Medicine – Ophthalmology).